Axogen (AXGN) Selling, General & Administrative (2010 - 2026)
Axogen (AXGN) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 3.74 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.28 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 3.06 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.78 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 522.20 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 349.70 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 1.12 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -207.22 Mn |
| 10 | Axogen | 2.12 Bn | 2.02 Bn | 46.19 Mn | 12.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.87 Mn |
| Dec 31, 2025 | 14.59 Mn |
| Sep 30, 2025 | 10.84 Mn |
| Jun 30, 2025 | 9.69 Mn |
| Mar 31, 2025 | 9.46 Mn |
| Dec 31, 2024 | 8.83 Mn |
| Sep 30, 2024 | 10.83 Mn |
| Jun 30, 2024 | 9.42 Mn |
| Mar 31, 2024 | 9.96 Mn |
| Dec 31, 2023 | 7.93 Mn |
| Sep 30, 2023 | 9.87 Mn |
| Jun 30, 2023 | 10.55 Mn |
| Mar 31, 2023 | 10.06 Mn |
| Dec 31, 2022 | 13.09 Mn |
| Sep 30, 2022 | 8.80 Mn |
| Jun 30, 2022 | 9.40 Mn |
| Mar 31, 2022 | 9.62 Mn |
| Dec 31, 2021 | 7.43 Mn |
| Sep 30, 2021 | 7.88 Mn |
| Jun 30, 2021 | 8.67 Mn |